Thus, after disassembly, DOX-KGFRWR has synergistic effects in anti-tumor therapy; it binds with the extracellular enzyme MMP-2 to inhibit the migration of cancer cells, and it also crosses the cell membrane via endocytosis and enters the nucleus to downregulate cancer cell mitosis. Here, MMP2 is linked to cancer.